Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment-Reference-Cited by-同舟云学术

Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment

Published:2022-12 Issue: Volume:129 Page:106168
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Liu Wenjie,Tian Liting,Wu Limeng,Chen Huanhua,Wang Nan,Liu Xin,Zhao Changhao,Wu Zhongchan,Jiang Xiaowen,Wu Qiong,Xu Zihua,Liu Wenwu,Zhao Qingchun^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference50 articles.

1. Classics in chemical neuroscience: memantine;Alam;ACS Chem. Neurosci.,2017

2. Progress in target drug molecules for Alzheimer's disease;Xie;Curr. Top. Med. Chem.,2020

3. Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3beta inhibitors;Prati;Angew. Chem. Int. Ed. Engl.,2015

4. A Multifunctional chemical agent as an attenuator of amyloid burden and neuroinflammation in Alzheimer's disease;Cho;ACS Chem. Neurosci.,2020

5. Management of oxidative stress and other pathologies in Alzheimer's disease;Simunkova;Arch. Toxicol.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer’s Disease;Molecules;2024-04-14

3. Design, Synthesis and Evaluation of 8‐(Piperazin‐1‐yl) Imidazo[1,2‐a]Pyrazine Derivatives as Acetylcholinesterase Inhibitors and Antioxidants;ChemistrySelect;2024-04-11

4. Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s disease;Drug Discovery Today;2024-04

5. Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects;European Journal of Medicinal Chemistry;2024-02